Hyperspectral imaging in head and neck tumors and malignant non-melanotic skin tumors

Recruiting

• Conditions: Malignant neoplasm of the oral cavity, oropharynx, hypopharynx, larynxnon-melanotic skin tumor in the head and neck area; C14.8; C10.8; C32.8; C13.8; D23.9; Overlapping lesion of lip, oral cavity and pharynx; Overlapping lesion of oropharynx; Overlapping lesion of larynx; Overlapping lesion of hypopharynx

• Registration Number: DRKS00033009
• Lead Sponsor: niversitätsklinik Jena, Klinik für Hals-, Nasen- und Ohrenheilkunde

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-11-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with (suspected) head and neck tumor
Patients with (suspected) non-melanotic skin tumor in the head and neck area
Written informed consent of the patient to participate in the study

Exclusion Criteria

Absence of informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary aim of the study is to test the suitability of HSI imaging for the acquisition of HSI image data of tumors in vivo.

Secondary Outcome Measures

Name	Time	Method
The secondary objective is to obtain initial data for the identification of features in the HSI image data that correlate with annotations (pathological findings). This will be used to develop an artificial intelligence (AI) model for tumor diagnostics.